22 September 2021 in Blood Advances
Multiple myeloma (MM) is a plasma cell malignancy characterized by the presence of multiple foci in the skeleton. These distinct tumor foci represent cycles of tumor growth and dissemination that seed new clusters and drive disease progression. By using an intratibial Vk*MYC murine myeloma model, we found that CD169+ radiation-resistant tissue-resident macrophages (MPs) were critical for early dissemination of myeloma and disease progression. Depletion of these MPs had no effect on tumor proliferation, but it did reduce egress of myeloma from bone marrow (BM) and its spread to other bones. Depletion of MPs as a single therapy and in combination with BM transplantation improved overall survival. Dissemination of myeloma was correlated with an increased inflammatory signature in BM MPs. It was also correlated with the production of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) by tumor-associated MPs. Exogenous intravenous IL-6 and TNFα can trigger myeloma intravasation in the BM by increasing vascular permeability in the BM and by enhancing the motility of myeloma cells by reducing the adhesion of CD138. Moreover, mice that lacked IL-6 had defects in disseminating myeloma similar to those in MP-depleted recipients. Mice that were deficient in TNFα or TNFα receptor (TNFR) had defects in disseminating MM, and engraftment was also impaired. These effects on dissemination of myeloma required production of cytokines in the radiation-resistant compartment that contained these radiation-resistant BM MPs. Taken together, we propose that egress of myeloma cells from BM is regulated by localized inflammation in foci, driven in part by CD169+ MPs.
11 January 2023 in The Journal of Immunology
Both infection and autoimmune disease can disrupt pre-existing Ab titers leading to diminished serological memory, yet the underlying mechanisms are not well understood. In this article, we report that TNF-α, an inflammatory cytokine, is a master regulator of the plasma cell (PC) niche in the bone marrow (BM). Acute rTNF-α treatment depletes previously existing Ab titers after vaccination by limiting PC occupancy or retention in the BM. Consistent with this phenomenon, mice lacking TNF-α signaling have elevated PC capacity in the BM and higher Ab titers. Using BM chimeric mice, we found that PC egress from the BM is regulated in a cell-extrinsic manner, by radiation-resistant cells via TNF-α receptor 1 signaling, leading to increased vascular permeability and CD138 downregulation on PCs. PC motility and egress in the BM are triggered within 6 h of recombinant TNF-α treatment. In addition to promoting egress, TNF-α signaling also prevented re-engraftment into the BM, leading to reduced PC survival. Although other inflammatory stimuli can promote PC egress, TNF-α signaling is necessary for limiting the PC capacity in the BM. Collectively, these data characterize how TNF-α–mediated inflammation attenuates the durability of serological memory and shapes the overall size and composition of the Ab-secreting cell pool in the BM.
18 October 2024 in Annals of Allergy, Asthma & Immunology
20 April 2026 in OTO Open
Objective: Surgeon‐Scientists in Otolaryngology‐Head and Neck Surgery (OHNS) are critical to advancing clinical care through scientific innovation. However, extended training duration and challenges in research funding acquisition continue to hinder career advancement. Study Design: Cross‐sectional cohort study. Setting: Analysis of publicly available NIH RePORTER data and national survey of NIH‐funded OHNS faculty across US academic medical institutions. Survey data was collected between October and December 2024. Methods: We identified NIH‐funded OHNS faculty as of September 2024 using the NIH RePORTER database. We examined time to initial R01‐equivalent funding and grant diversity by degree types (MD, PhD, or dual‐degree). A survey was administered to the OHNS faculty to evaluate their training experiences, research productivity, and funding mechanisms. Results: PhD faculty comprised the largest proportion of NIH‐funded OHNS investigators (52%) and had greater grant diversity than MD and dual‐degree counterparts ( P < .0001). Furthermore, PhDs secured R01‐equivalent grants earlier than MDs and dual‐degree holders (7.5 vs 9.5 years posttraining, P = .04). However, MD and dual‐degree faculty were more likely to obtain K awards and transition to R01 funding ( P < .0001). Participation in T32/R25 residency programs was associated with a 2.5‐year reduction in time to R01‐equivalent grant ( P = .037). Basic science researchers were 4 times more likely to obtain K awards ( P = .04). Conclusion: While OHNS PhD faculty attain early and diverse funding, structured training programs and engagement in basic science research significantly enhance MD‐degree faculty funding success. This study highlights institutional and training‐level strategies that reduce the time to research independence and strengthen the OHNS surgeon‐scientist pipeline.